Recombinant Leukemia Inhibitory Factor Receptor (LIFR)
#
-
Catalog numberRPU42533-100ug
-
Price:
-
Size100ug
-
-
Estimated Turnaround Time6-11 business days
-
Gene NameNA
-
Alternative NamesCD118; SJS2; STWS; SWS
-
SourceE.coli
-
Purity≥ 92%
-
ApplicationPositive Control; Immunogen; SDS-PAGE; WB.
-
Shipping ConditionsIce packs
-
Storage conditionsShort term: -20°C; Long term: -80°C. Minimize freeze and thaw cycles.
-
Shelf life1 year
-
RestrictionFor research use only. Not for diagnostic procedures.
-
DescriptionAplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells. The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.
-
Additional sourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Gene symbolLIFR-AS1, LIFR
-
Short nameRecombinant Leukemia Inhibitory Factor Receptor (LIFR)
-
TechniqueRecombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. Biomatik advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
SpeciesHomo sapiens (Human)
-
Alternative nameRec. Leukemia Inhibitory Factor Receptor (leukemia inhibitory factor receptor alpha)
-
Alternative techniquerec
-
Alternative to gene targetleukemia inhibitory factor receptor alpha, CD118 and LIF-R and SJS2 and STWS and SWS, LIFR and IDBG-17489 and ENSG00000113594 and 3977, growth factor binding, Extracellular, Lifr and IDBG-128297 and ENSMUSG00000054263 and 16880, LIFR and IDBG-630017 and ENSBTAG00000010423 and 539504
-
Virusleukemia
-
Gene info
-
Identity
-
Gene
-
Long gene nameLIFR antisense RNA 1
-
Synonyms gene name
- LIFR antisense RNA 1 (non-protein coding)
-
GenBank acession
-
Locus
-
Discovery year2011-11-23
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Antisense RNAs
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene nameLIF receptor subunit alpha
-
Synonyms gene name
- leukemia inhibitory factor receptor
- leukemia inhibitory factor receptor alpha
- LIF receptor alpha
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1992-08-24
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Fibronectin type III domain containing
- CD molecules
- MicroRNA protein coding host genes
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
-
Tree numbers
- C04.557.337.372
- C04.619.531
- E05.598.500.496.500
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery